West Virginia Pharmacists Association

109th Annual Convention

~

October 8 – 9, 2016

Charleston Marriott Town Center Charleston, WV

WVPA 2016 Annual Convention A two-day convention designed for pharmacists, pharmacy technicians, residents, and students. Participants will have an opportunity to attend sessions on an array of contemporary pharmacy topics including: immunization updates, naloxone, student self-care challenge, preceptor development, new drugs, harm reduction, and pharmacy law updates. Dr. Jean-Venable “Kelly” R. Goode, President of the American Pharmacists Association (APhA), will deliver the featured presentation on ways to advance pharmacy practice.

Continuing Education Credit

The West Virginia University School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education

as a provider of continuing pharmacy education (CPE). Pharmacists can receive up to a total of 14.5 contact hours (1.45 CEUs) of CPE (sessions with ACPE numbers ending in a “P”). Pharmacy technicians can receive up to a total of 7.5 contact hours (0.75 CEUs) of continuing education (ACPE numbers ending in a “T”). There are up to 6.5 contact hours (0.65 CEUs) of CPE for pharmacists on Saturday and 8.0 contact hours (0 .8 CEUs) on Sunday. There are up to 3.0 contact hours (0.30 CEUs) of CPE for technicians on Saturday and 4.5 contact hours (0.45 CEUs) on Sunday. WVUSoP will report your participation in the activity to NABP CPE Monitor within 4-6 weeks for all participants who successfully complete each session. Successful completion includes attending the entire session, signing the attendance sheet and completing an online evaluation form for

each session attended. Transcripts of CPE

can be printed from NABP CPE Monitor. If needed, statements of credit may be printed at https://pharmacyce.wvu.edu/user/login.

Convention Accommodations The 2016 Annual Convention is being held at Charleston Marriott Town Center in Charleston, WV. For reservations call 1-800-228-9290, or direct at 304-345-6500. The hotel is situated in downtown Charleston, West Virginia, at the junction of Routes 64, 77, and 79. A block of rooms will be available at a conference rate of $105 per night. Deadline to take advantage of these rates is September 9, 2016.

Charleston is the capitol of West Virginia and features a wide range of activities and attractions from the Clay Center for the Arts and Sciences, Capitol Market, the Cultural Center, Capitol Street, Haddad Riverfront Park, and Kanawha State Forest.

Charleston Marriott Town Center

8:00am – 5:30pm *APhA Pharmacy-Based Cardiovascular Disease Risk Management (Application Based)

Presented by West Virginia University School of Pharmacy Office of Continuing Education. *This activity is pending approval, and will have separate registration and cost. For more information, or to register, please contact the WVU School of Pharmacy at 304-293-5103 or http://pharmacy.hsc.wvu.edu/continuing-education/live-programs/.

7:00pm – 9:00pm WVPA Board of Directors Meeting and Dinner

7:00am Registration and Continental Breakfast

with Exhibitors

8:00am – 10:00am *A Shot of Prevention: A 2016 Immunization Update

Dani S. Dolin, PharmD, CDE, CPT ACPE UAN 0072-9999-16-101-L01-P

(Application-Based) Apply recent Advisory Committee on Immunization

Practice guidelines for adult vaccinations to clinical practice.

Review how to appropriately screen a patient prior to vaccination.

Differentiate between available influenza, tetanus-containing, pneumococcal, and meningococcal vaccines and determine how to select the most appropriate vaccine.

Summarize WV-specific immunization laws, regulations, and procedures specific to pharmacists. *This session was originally presented in Vienna, WV on April 24, 2016. If you attended this session additional credit will not be awarded.

10:00am – 10:25am Break with Exhibitors 10:25am Welcome – Richard Stevens

Executive Director, WVPA

Moderator - Krista Capehart WVPA President, 2014-2016

10:30am – 12:00pm

Friday, October 7, 2016

Saturday, October 8, 2016

Featured Presentation – Building a Community of Care Jean-Venable “Kelly” R. Goode, PharmD, BCPS, FAPhA, FCCP ACPE UAN 0072-9999-16-102-L04-P/T*(Application-Based)

Explain the current health care environment and the issues facing pharmacists.

Define community-based pharmacy practitioner and integrate the principles including collaborative practice and team-based care into your practice.

Evaluate opportunities for expanding a community of care in your practice.

Design a plan for expanding a community of care in your practice. *Pharmacists and Technicians learning objectives are the same.

Dr. Goode is the President of the American Pharmacists Association (APhA). She is Professor, Department of Pharmacotherapy and Outcomes Science, VCU School of Pharmacy and the Director of the VCU Community Pharmacy Residency Program. She worked for 10 years with Ukrop’s (now Martin’s) Pharmacy to develop enhanced patient care programs. Dr. Goode is currently a credentialed practitioner at the Daily Planet, Inc., a federally qualified health care center for the homeless where she has developed innovative pharmacist patient care programs within a patient-centered medical home. Dr. Goode has pharmacy practice experience in community, health-system, long-term care, managed care and home care.

Schedule of Events

Haddad Riverfront Park

Clay Center for the Arts and Sciences

12:00pm – 1:30pm Luncheon with Exhibitors, Tour of Exhibits, Door Prizes 1:30pm – 2:30pm House of Delegates (No CE) Join us to address and debate the current issues of West Virginia pharmacists and the West Virginia Pharmacists Association in a House

of Delegates style discussion.

Concurrent Sessions 2:30pm – 5:45pm To Breathe or Not to Breathe - That is the Question: What Pharmacists Need to Know About Naloxone Charles (CK) Babcock, PharmD, Mark Garofoli, PharmD, MBA, CGP, Elizabeth J. Scharman, PharmD, DABAT,

BCPS, FAACT ACPE UAN 0072-9999-16-103-L01-P (Application-Based)

Describe the pharmacology and classification of opiates and opioids based on chemical structure, mechanism of action, potency, and controlled substance classes.

List the morphine milligram equivalent for at least 4 opiates and opioids.

Identify common side effects associated with opiates and opioids and how to effectively counsel patients regarding expectations and management of the side effects.

Describe the “opioid epidemic” in relation to the history, prescribing patterns, and overdose patterns of opiates and opioids.

Identify signs and symptoms of opioid toxicity beyond the classic opioid toxidrome and describe the relationship between the type of opioid taken in overdose and the clinical effects to expect.

Describe the pharmacology of naloxone and use this information to predict response after naloxone administration.

List 4 reasons why an individual with an opioid overdose may not respond to naloxone.

Describe at least 3 reasons why medical care after naloxone administration is required.

Discuss how to use intranasal and intramuscular Naloxone.

Identify the possible responses to intranasal and intramuscular Naloxone.

Prepare and administer intranasal and intramuscular Naloxone.

Describe how continued support should be provided to the overdose victim. *This session was originally presented in Flatwoods, WV on June 12, 2016. If you attended this session additional credit will not be awarded.

2:30pm – 4:00pm NASPA – NMA Student Pharmacist Self-Care Championship (CE for Pharmacists and Technicians)

Krista D Capehart, PharmD, MSPharm, AE-C, Donald Allison, PharmD, Abbi Blevins, PharmD, MBA, Zach Pape, PharmD ACPE UAN 0072-9999-16-104-L04-P/T* (Knowledge-Based)

Identify and explain aspects of the effective and safe practice of pharmacy self-care treatments.

Describe at least two over the counter and prescription medication interactions that pharmacists and pharmacy technicians should be aware of.

List three OTC medications and their use. Pharmacists should identify counseling points for each of three OTC medications. *Pharmacists and Technicians learning objectives are the same.

4:00pm – 4:15pm Break 4:15pm – 5:45pm Resume Naloxone Presentation

6:00pm – 7:00pm Reception Honoring WVPA Past Presidents

7:00pm – 9:00pm 109

th Annual Convention Installation and Awards Dinner

Note: Dress is business casual for this event.

7:00am – 9:30am Registration and Continental Breakfast Pre-Conference Session for Pharmacists and Pharmacy Technicians Please note – this session has a separate registration and registration fee in addition to the regular conference registration fees. Please see the registration form for details. 7:00am – 10:00am Updates in Prescription Drug Diversion,

Substance Use Disorders and Pain Management Michael O’Neil, PharmD Richard Stevens, Executive Director of WVPA ACPE UAN 0072-9999-16-119-L03-P (Knowledge-Based) (3.0 CE contact hours) ACPE UAN 0072-9999-16-120-L04-T (Knowledge-Based) (1.5 CE contact hours)

Sunday, October 9, 2016

Pharmacist Objectives

Discuss what comprises drug diversion, including West Virginia statistics on prescription drug abuse and resulting deaths.

State the epidemiology of chronic pain and misuse of opioids.

Describe the indicators for opioids in chronic pain treatment including general characteristics, toxicities, and drug interactions.

Outline patient evaluation and risk assessment and tools to assess risk and monitor benefits.

Explain the initiation and ongoing-management of chronic pain in patients treated with opioid based therapies.

Discuss a case study of a patient with chronic pain.

Identify diversion and drug seeking behaviors and tactics.

State best practice methods for working with patients, prescribers, and law enforcement concerning patients suspected of drug seeking behavior and diversion.

Give examples of compliance with controlled substances laws.

Identify registration with and use of the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60 A-9-1.

Technician Objectives

Discuss what comprises drug diversion, including West Virginia statistics on prescription drug abuse and resulting deaths.

Identify diversion and drug seeking behaviors and tactics.

State best practice methods for working with patients, prescribers, and law enforcement concerning patients suspected of drug seeking behavior and diversion.

Give examples of compliance with controlled substances laws.

Identify registration with and use of the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60 A-9-1.

10:00am – 10:15am Welcome – Craig Kimble, WVPA President Elect 2016-2018 10:15am – 12:15pm Recent Pharmacological and Therapeutic Developments Affecting Pharmacists

Glen E. Farr, PharmD ACPE UAN 0072-9999-16-106-L04-P (Application-Based)

• Identify essential information to more effectively counsel patients on recently introduced drugs. • Compare and contrast changes in the current therapeutic approach to various disease processes. • Evaluate evidence-based studies to appropriately respond to questions and concerns from prescribers and patients on recent

reports in the health professions literature.

12:15pm to 1:00pm Lunch Concurrent Sessions 1:00pm – 2:30pm The New 2016 ACPE Standards for Schools of Pharmacy

Preceptor, Are you ready? Craig Kimble, PharmD, MBA, MS, BCACP, Melanie Butt, BBA, R. Gail Rice, Robert B. Stanton, MBA, PharmD, BCPS ACPE UAN 0072-9999-16-105-L04-P (Application-Based)

Analyze changes in ACPE standards for 2016.

Develop a list of areas of your practice that will require modification.

Create strategies on how your practice will meet the new 2016 requirements.

Impact of a Harm Reduction Program in West Virginia Lindsay Acree, PharmD, AE-C, TTC, Timothy Hazelett, BS ACPE UAN 0072-9999-16-107-L04-P/T* (Knowledge-Based)

Identify goals of the Harm Reduction Clinic.

Discuss the statistics surrounding the Harm Reduction Clinic.

Describe areas that may benefit from needle exchange programs. *Pharmacists and Technicians learning objectives are the same.

2:30pm – 4:00pm The Latest in Pharmacy Law and How to Comply: 2016 Krista D. Capehart, PharmD, MSPharm, AE-C

ACPE UAN 0072-9999-16-108-L03-P/T* (Knowledge-Based) Discuss laws passed by the 2015 WV Legislature related to pharmacy practice.

Identify the expansion in types of immunizations given by West Virginia pharmacists.

Discuss federal changes for compounding for prescriptions and for 503b outsourcing facilities. *Pharmacists and Technicians learning objectives are the same.

4:00pm Questions, Evaluations, and Adjournment

Lindsay Acree, PharmD, AE-C, TTC, Assistant Professor, Pharmacy Practice Department, University of Charleston School of Pharmacy, Pharmacist-In-Charge, PharmUC Patient Care Clinic, Charleston, WV Donald Allison, PharmD, West Virginia University School of Pharmacy – Kroger Community Pharmacy Resident, Charleston, WV Charles (CK) Babcock, PharmD, Assistant Professor, Department of Pharmacy Practice, Administration and Research Marshall University School of Pharmacy, Huntington, WV Abbi Blevins, PharmD, MBA, West Virginia University School of Pharmacy – Kroger Community Pharmacy Resident, Morgantown, WV Melanie Butt, BBA, APPE Coordinator, Marshall University School of Pharmacy, Huntington, WV Krista D Capehart, PharmD, MSPharm, AE-C, Clinical Associate Professor, Director of the Wigner Institute for Advanced Pharmacy Practice, Education and Research, West Virginia University School of Pharmacy, Morgantown, WV Dani Dolin, PharmD, CDE, CPT, Clinical Pharmacist, Morgantown, WV Glen E. Farr, PharmD, Professor of Clinical Pharmacy , University of Tennessee College of Pharmacy, Knoxville, TN Timothy Hazelett, BS, Administrator for Cabell-Huntington Health Department, Huntington, WV Mark Garofoli, PharmD, MBA, CGP, Assistant Professor and Pain Management Specialist, West Virginia University School of Pharmacy, Morgantown, WV Jean-Venable "Kelly" R. Goode, Pharm.D, BCPS, FAPhA, FCCP, Professor and Director, Community Pharmacy Residency Program School of Pharmacy, Virginia Commonwealth University, Richmond, VA Craig Kimble, PharmD, MBA, MS, BCACP, Director of Experiential Learning, Manager of Clinical Support Services, Assistant Professor of Pharmacy Practice, Marshall University School of Pharmacy, Huntington, WV Michael O’Neil, PharmD, Professor and Chair Department of Pharmacy Practice, Drug Diversion, Substance Abuse and Pain Management Consultant, South College School of Pharmacy, Knoxville, TN Zach Pape, PharmD, West Virginia University School of Pharmacy – Waterfront Family Pharmacy Community Pharmacy Resident, Morgantown, WV R. Gail Rice, IPPE Coordinator, Marshall University School of Pharmacy, Huntington, WV Elizabeth J. Scharman, PharmD, DABAT, BCPS, FAACT, Director, WV Poison Center, Professor, Department Clinical Pharmacy, West Virginia University School of Pharmacy, Charleston, WV Robert B. Stanton, MBA, PharmD, BCPS, Assistant Dean, Experiential Learning, Marshall University School of Pharmacy, Huntington, WV Richard Stevens, Executive Director, West Virginia Pharmacists Association, Charleston, WV

Activity Faculty

Capitol Street

Name: ______________________________________________________________________RPh PharmD Other ______________ Address: ___________________________________________________________________________________________________ Spouse: __________________________________________Guests:___________________________________________________ Tel: (_____)__________________ FAX: (_____)_____________________E-mail: _______________________________________

Registration Fees - Each fee increases $50 after September 19th

. Register for the Convention October 8-9, or register for a single day October 8

th or October 9

th.

FULL CONFERENCE: Registration includes up to 14.5 contact hours of CE (ACPE-approved) for pharmacists and 7.5 contact hours for technicians, participant handouts, refreshment breaks, continental breakfasts, lunches, reception, dinner, and special events as noted in the activity.

SINGLE DAY: October 8th

registration includes up to 6.5 contact hours of CE (ACPE-approved) for pharmacists and 3.0 contact hours for technicians, participant handouts, continental breakfast, luncheon, breaks, reception, and dinner. October 9

th registration

includes up to 8.0 contact hours of CE (ACPE-approved) for pharmacists and 4.5 contact hours for technicians, participant handouts, continental breakfast, lunch, and breaks.

DRUG DIVERSION: This pre-conference session has an additional fee of $60 for both pharmacists and pharmacy technicians.

Both Days Single Day Single Day Fees (PLEASE Circle Fees Paid) October 8/9 October 8 October 9

WVPA or WVSHP member pharmacist $260 $180 $140 Non-member pharmacist or company representative $440 $280 $240 Pharmacy Technician $100 $70 $50 Resident $180 $120 $80 Student $180 $120 $80 Spouse and/or each guest $100 $90 $50 Drug Diversion (for pharmacists and pharmacy technicians) $60 Additional Fee per Person after September 19

th $50 $50 $50

TOTAL $_______ $_______ $_______ Attendance (PLEASE Indicate Number of Persons Attending the Following Events)

October 8

th Number Attending

Continental Breakfast ____ Luncheon w/Exhibitors ____ Reception ____ Banquet ____

October 9th

Number Attending

Continental Breakfast ____ Lunch ____ Preceptor CE Session ____

Drug Diversion ____

$__________ check enclosed payable to WVPA ...or... Charge my _____ Visa or _____ MasterCard

Account #_____________________________________________________________ Exp. Date ____/_____Security Code________

Name on Account_______________________________________________________

Signature______________________________________________________________ Date______/_________/__________________

Are you a new member or “first timer”? Please check the appropriate box below:

□ New Member (joined in the past 12 months for the first time)

□ First Timer (first WVPA annual convention meeting attended)

REGISTRATION

WVPA 109th

ANNUAL CONVENTION, October 8-9, 2016 – Charleston Marriott Town Center, Charleston, WV Mail to: WVPA, 2016 ½ Kanawha Blvd., East, Charleston, WV 25311

Tel: 304-344-5302, Fax: 304-344-5316, Email: wvrds@aol.com